Finally, among the group of 30-day-interval doses, we detected a significant increase in AKI-MP stimulated populations in the case of both CD8+ and CD8+CD45RO+ memory T cells on D7, D33, and D60, but no significant change was found for G33D (Figure 3e,f). Here, CD8A is linked to acute kidney injury.